MicroRNA-212 displays tumor-promoting properties in non-small cell lung cancer cells and targets the hedgehog pathway receptor PTCH1

Molecular Biology of the Cell

Volumn 23, Issue 8, 2012, Pages 1423-1434

  Li, Yuan ^a   Zhang, Deqiang ^a   Chen, Chengwen ^a   Ruan, Zhenchao ^a   Li, Yao ^a   Huang, Yan ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

4 O METHYLPHORBOL 13 ACETATE 12 MYRISTATE; MICRORNA; MIR 212; PROTEIN PATCHED 1; SONIC HEDGEHOG PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CANCER CELL CULTURE; CARCINOGENESIS; CELL CYCLE PROGRESSION; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; LUNG NON SMALL CELL CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; RECEPTOR UPREGULATION; TUMOR PROMOTION;

ANTIBODIES, MONOCLONAL; CARCINOMA, NON-SMALL-CELL LUNG; CELL CYCLE; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HEDGEHOG PROTEINS; HUMANS; LUNG NEOPLASMS; MICRORNAS; RECEPTORS, CELL SURFACE; RNA INTERFERENCE; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TETRADECANOYLPHORBOL ACETATE;

ERINACEIDAE;

EID: 84859732471     PISSN: 10591524     EISSN: 19394586     Source Type: Journal    
DOI: 10.1091/mbc.E11-09-0777     Document Type: Article

References (84)

1. Adolphe C, Hetherington R, Ellis T, Wainwright B (2006). Patched1 functions as a gatekeeper by promoting cell cycle progression. Cancer Res 66, 2081-2088.
2. Barnes EA, Kong M, Ollendorff V, Donoghue DJ (2001). Patched1 interacts with cyclin B1 to regulate cell cycle progression. EMBO J 20, 2214-2223. (Pubitemid 32410591)
3. Bartel DP (2004). MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116, 281-297.
4. Berman DM et al. (2002). Medulloblastoma growth inhibition by hedgehog pathway blockade. Science 297, 1559-1561. (Pubitemid 34971004)
5. Berman DM et al. (2003). Widespread requirement for Hedgehog ligand stimulation in growth of digestive tract tumours. Nature 425, 846-851. (Pubitemid 37351469)
6. Brandner S (2010). Nanog, Gli, and p53: a new network of stemness in development and cancer. EMBO J 29, 2475-2476.
7. Calin GA et al. (2002). Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci USA 99, 15524-15529. (Pubitemid 35403967)
8. Calin GA et al. (2004). Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci USA 101, 2999-3004. (Pubitemid 38327724)
9. Calin GA, Croce CM (2006). MicroRNA signatures in human cancers. Nat Rev Cancer 6, 857-866. (Pubitemid 44629897)
10. Chan JA, Krichevsky AM, Kosik KS (2005). MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res 65, 6029-6033. (Pubitemid 40994386)
11. Choi SW, Park SW, Lee KY, Kim KM, Chung YJ, Rhyu MG (1998). Fractional allelic loss in gastric carcinoma correlates with growth patterns. Oncogene 17, 2655-2659.
12. Cui C, Elsam T, Tian Q, Seykora JT, Grachtchouk M, Dlugosz A, Tseng H (2004). Gli proteins up-regulate the expression of basonuclin in basal cell carcinoma. Cancer Res 64, 5651-5658. (Pubitemid 39095561)
13. Dahmane N, Lee J, Robins P, Heller P, Ruiz IAA (1997). Activation of the transcription factor Gli1 and the Sonic hedgehog signalling pathway in skin tumours. Nature 389, 876-881.
14. Eichberger T, Kaser A, Pixner C, Schmid C, Klingler S, Winklmayr M, Hauser-Kronberger C, Aberger F, Frischauf AM (2008). GLI2-specific transcriptional activation of the bone morphogenetic protein/activin antagonist follistatin in human epidermal cells. J Biol Chem 283, 12426-12437.
15. Eis PS, Tam W, Sun L, Chadburn A, Li Z, Gomez MF, Lund E, Dahlberg JE (2005). Accumulation of miR-155 and BIC RNA in human B cell lymphomas. Proc Natl Acad Sci USA 102, 3627-3632. (Pubitemid 40354662)
16. Esquela-Kerscher A, Slack FJ (2006). Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer 6, 259-269.
17. Fan H, Oro AE, Scott MP, Khavari PA (1997). Induction of basal cell carcinoma features in transgenic human skin expressing Sonic Hedgehog. Nat Med 3, 788-792.
18. Ferretti E et al. (2008). Concerted microRNA control of Hedgehog signalling in cerebellar neuronal progenitor and tumour cells. EMBO J 27, 2616-2627.
19. Fiedler SD, Carletti MZ, Hong X, Christenson LK (2008). Hormonal regulation of microRNA expression in periovulatory mouse mural granulosa cells. Biol Reprod 79, 1030-1037.
20. Flynt AS, Li N, Thatcher EJ, Solnica-Krezel L, Patton JG (2007). Zebrafish miR-214 modulates Hedgehog signaling to specify muscle cell fate. Nat Genet 39, 259-263. (Pubitemid 46184359)
21. Friggi-Grelin F, Lavenant-Staccini L, Therond P (2008). Control of antagonistic components of the hedgehog signaling pathway by microRNAs in Drosophila. Genetics 179, 429-439.
22. Garg R, Ramchandani AG, Maru GB (2008). Curcumin decreases 12-O-tetradecanoylphorbol-13-acetate-induced protein kinase C translocation to modulate downstream targets in mouse skin. Carcinogenesis 29, 1249-1257. (Pubitemid 351958706)
23. Gaur A, Jewell DA, Liang Y, Ridzon D, Moore JH, Chen C, Ambros VR, Israel MA (2007). Characterization of microRNA expression levels and their biological correlates in human cancer cell lines. Cancer Res 67, 2456-2468. (Pubitemid 46548930)
24. Gebeshuber CA, Zatloukal K, Martinez J (2009). miR-29a suppresses tristetraprolin, which is a regulator of epithelial polarity and metastasis. EMBO Rep 10, 400-405.
25. Gialmanidis IP, Bravou V, Amanetopoulou SG, Varakis J, Kourea H, Papadaki H (2009). Overexpression of hedgehog pathway molecules and FOXM1 in non-small cell lung carcinomas. Lung Cancer 66, 64-74.
26. Gleeson CM, Sloan JM, McGuigan JA, Ritchie AJ, Weber JL, Russell SE (1997). Allelotype analysis of adenocarcinoma of the gastric cardia. Br J Cancer 76, 1455-1465. (Pubitemid 27501128)
27. Goel G, Makkar HP, Francis G, Becker K (2007). Phorbol esters: structure, biological activity, and toxicity in animals. Int J Toxicol 26, 279-288. (Pubitemid 47174587)
28. Goodrich LV, Milenkovic L, Higgins KM, Scott MP (1997). Altered neural cell fates and medulloblastoma in mouse patched mutants. Science 277, 1109-1113. (Pubitemid 27371635)
29. Grachtchouk M, Mo R, Yu S, Zhang X, Sasaki H, Hui CC, Dlugosz AA (2000). Basal cell carcinomas in mice overexpressing Gli2 in skin. Nat Genet 24, 216-217. (Pubitemid 30132187)
30. Gribben L, Baxter RC, Marsh DJ (2011). Insulin-like growth factor binding protein-3 inhibits migration of endometrial cancer cells. Cancer Lett 17, 41-48.
31. Gustafsson MK, Pan H, Pinney DF, Liu Y, Lewandowski A, Epstein DJ, Emerson CJ (2002). Myf5 is a direct target of long-range Shh signaling and Gli regulation for muscle specification. Genes Dev 16, 114-126. (Pubitemid 34049642)
32. Hahn H (2006). Mode of PTCH1Ptch1-associated tumor formation: insights from mutant Ptch1 mice. In: Hedgehog-GLI Signaling in Human Disease, ed. AR Attaba, New York: Springer, 53-62.
33. Hahn H et al. (1996). Mutations of the human homolog of Drosophila patched in the nevoid basal cell carcinoma syndrome. Cell 85, 841-851. (Pubitemid 26192135)
34. Hahn H, Wojnowski L, Zimmer AM, Hall J, Miller G, Zimmer A (1998). Rhabdomyosarcomas and radiation hypersensitivity in a mouse model of Gorlin syndrome. Nat Med 4, 619-622. (Pubitemid 28237364)
35. He H et al. (2005). The role of microRNA genes in papillary thyroid carcinoma. Proc Natl Acad Sci USA 102, 19075-19080. (Pubitemid 43049568)
36. He L et al. (2005). A microRNA polycistron as a potential human oncogene. Nature 435, 828-833. (Pubitemid 40839734)
37. Hollander JA, Im HI, Amelio AL, Kocerha J, Bali P, Lu Q, Willoughby D, Wahlestedt C, Conkright MD, Kenny PJ (2010). Striatal microRNA controls cocaine intake through CREB signalling. Nature 466, 197-202.
38. Inaguma S, Kasai K, Ikeda H (2011). GLI1 facilitates the migration and invasion of pancreatic cancer cells through MUC5AC-mediated attenuation of E-cadherin. Oncogene 30, 714-723.
39. Incoronato M, Garofalo M, Urso L, Romano G, Quintavalle C, Zanca C, Iaboni M, Nuovo G, Croce CM, Condorelli G (2010). miR-212 increases tumor necrosis factor-related apoptosis-inducing ligand sensitivity in non-small cell lung cancer by targeting the antiapoptotic protein PED. Cancer Res 70, 3638-3646.
40. Ingham PW (1998). Transducing Hedgehog: the story so far. EMBO J 17, 3505-3511.
41. Iorio MV et al. (2005). MicroRNA gene expression deregulation in human breast cancer. Cancer Res 65, 7065-7070. (Pubitemid 41161233)
42. Jansson KH, Lynch JE, Lepori-Bui N, Czymmek KJ, Duncan RL, Sikes RA (2011). Overexpression of the VSSC-associated CAM, beta-2, enhances LNCaP cell metastasis associated behavior. Prostate. doi: 10.1002/pros.21512.
43. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011). Global cancer statistics. CA Cancer J Clin 61, 69-90.
44. Johnson RL et al. (1996). Human homolog of patched, a candidate gene for the basal cell nevus syndrome. Science 272, 1668-1671. (Pubitemid 26200029)
45. Kim HJ et al. (2006). Phorbol ester potentiates the growth inhibitory effects of troglitazone via up-regulation of PPARγ in A549 cells. Biochem Biophys Res Commun 349, 660-667. (Pubitemid 44344567)
46. Kim JC, Yu JH, Cho YK, Jung CS, Ahn SH, Gong G, Kim YS, Cho DH (2011). Expression of SPRR3 is associated with tumor cell proliferation in less advanced stages of breast cancer. Breast Cancer Res Treat. doi: 10.1007/s10549-011-1868- 5.
47. Kinzler KW, Bigner SH, Bigner DD, Trent JM, Law ML, O'Brien SJ, Wong AJ, Vogelstein B (1987). Identification of an amplified, highly expressed gene in a human glioma. Science 236, 70-73. (Pubitemid 17056814)
48. Kluiver J, Kroesen BJ, Poppema S, van den Berg A (2006). The role of microRNAs in normal hematopoiesis and hematopoietic malignancies. Leukemia 20, 1931-1936. (Pubitemid 44614880)
49. Kozaki K, Imoto I, Mogi S, Omura K, Inazawa J (2008). Exploration of tumor-suppressive microRNAs silenced by DNA hypermethylation in oral cancer. Cancer Res 68, 2094-2105. (Pubitemid 351521781)
50. Lagos-Quintana M, Rauhut R, Lendeckel W, Tuschl T (2001). Identification of novel genes coding for small expressed RNAs. Science 294, 853-858. (Pubitemid 33032103)
51. Lee EJ, Gusev Y, Jiang J, Nuovo GJ, Lerner MR, Frankel WL, Morgan DL, Postier RG, Brackett DJ, Schmittgen TD (2007). Expression profiling identifies microRNA signature in pancreatic cancer. Int J Cancer 120, 1046-1054. (Pubitemid 46214304)
52. Li X, Deng W, Nail CD, Bailey SK, Kraus MH, Ruppert JM, Lobo-Ruppert SM (2006). Snail induction is an early response to Gli1 that determines the efficiency of epithelial transformation. Oncogene 25, 609-621. (Pubitemid 43164471)
53. Lu J et al. (2005). MicroRNA expression profiles classify human cancers. Nature 435, 834-838. (Pubitemid 40839735)
54. Matsuzaki Y, Takaoka Y, Hitomi T, Nishino H, Sakai T (2004). Activation of protein kinase C promotes human cancer cell growth through down-regulation of p18(INK4c). Oncogene 23, 5409-5414. (Pubitemid 39005817)
55. Michael MZ, O'Connor SM, van Holst PN, Young GP, James RJ (2003). Reduced accumulation of specific microRNAs in colorectal neoplasia. Mol Cancer Res 1, 882-891. (Pubitemid 37288707)
56. Nilsson M, Unden AB, Krause D, Malmqwist U, Raza K, Zaphiropoulos PG, Toftgard R (2000). Induction of basal cell carcinomas and trichoepitheliomas in mice overexpressing GLI-1. Proc Natl Acad Sci USA 97, 3438-3443. (Pubitemid 30183321)
57. O'Donnell KA, Wentzel EA, Zeller KI, Dang CV, Mendell JT (2005). c-Myc-regulated microRNAs modulate E2F1 expression. Nature 435, 839-843. (Pubitemid 40839736)
58. Oro AE, Higgins KM, Hu Z, Bonifas JM, Epstein EJ, Scott MP (1997). Basal cell carcinomas in mice overexpressing sonic hedgehog. Science 276, 817-821. (Pubitemid 27199865)
59. Park JK, Henry JC, Jiang J, Esau C, Gusev Y, Lerner MR, Postier RG, Brackett DJ, Schmittgen TD (2011). miR-132 and miR-212 are increased in pancreatic cancer and target the retinoblastoma tumor suppressor. Biochem Biophys Res Commun 406, 518-523.
60. Pasca DMM, Hebrok M (2003). Hedgehog signalling in cancer formation and maintenance. Nat Rev Cancer 3, 903-911.
61. Rabinowits G, Gercel-Taylor C, Day JM, Taylor DD, Kloecker GH (2009). Exosomal microRNA: a diagnostic marker for lung cancer. Clin Lung Cancer 10, 42-46.
62. Regl G, Kasper M, Schnidar H, Eichberger T, Neill GW, Philpott MP, Esterbauer H, Hauser-Kronberger C, Frischauf AM, Aberger F (2004). Activation of the BCL2 promoter in response to Hedgehog/GLI signal transduction is predominantly mediated by GLI2. Cancer Res 64, 7724-7731. (Pubitemid 39446903)
63. Rizvi S, Demars CJ, Comba A, Gainullin VG, Rizvi Z, Almada LL, Wang K, Lomberk G, Fernandez-Zapico ME, Buttar NS (2010). Combinatorial chemoprevention reveals a novel smoothened-independent role of GLI1 in esophageal carcinogenesis. Cancer Res 70, 6787-6796.
64. Sequeira L, Dubyk CW, Riesenberger TA, Cooper CR, van Golen KL (2008). Rho GTPases in PC-3 prostate cancer cell morphology, invasion and tumor cell diapedesis. Clin Exp Metastasis 25, 569-579.
65. Sheng T, Li C, Zhang X, Chi S, He N, Chen K, McCormick F, Gatalica Z, Xie J (2004). Activation of the hedgehog pathway in advanced prostate cancer. Mol Cancer 3, 29.
66. Singh S et al. (2011). Hedgehog-producing cancer cells respond to and require autocrine Hedgehog activity. Cancer Res 71, 4454-4463.
67. Taipale J, Beachy PA (2001). The Hedgehog and Wnt signalling pathways in cancer. Nature 411, 349-354. (Pubitemid 32467044)
68. Takamizawa J et al. (2004). Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res 64, 3753-3756. (Pubitemid 38697282)
69. Tang Y, Banan A, Forsyth CB, Fields JZ, Lau CK, Zhang LJ, Keshavarzian A (2008). Effect of alcohol on miR-212 expression in intestinal epithelial cells and its potential role in alcoholic liver disease. Alcohol Clin Exp Res 32, 355-364.
70. Taylor MD et al. (2002). Mutations in SUFU predispose to medulloblastoma. Nat Genet 31, 306-310.
71. Thayer SP et al. (2003). Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis. Nature 425, 851-856. (Pubitemid 37355945)
72. Toftgard R (2000). Hedgehog signalling in cancer. Cell Mol Life Sci 57, 1720-1731.
73. Ucar A, Vafaizadeh V, Jarry H, Fiedler J, Klemmt PA, Thum T, Groner B, Chowdhury K (2010). miR-212 and miR-132 are required for epithelial stromal interactions necessary for mouse mammary gland development. Nat Genet 42, 1101-1108.
74. Ventura A, Jacks T (2009). MicroRNAs and cancer: short RNAs go a long way. Cell 136, 586-591.
75. Vestergaard J, Pedersen MW, Pedersen N, Ensinger C, Tumer Z, Tommerup N, Poulsen HS, Larsen LA (2006). Hedgehog signaling in small-cell lung cancer: frequent in vivo but a rare event in vitro. Lung Cancer 52, 281-290. (Pubitemid 43674545)
76. Volinia S et al. (2006). A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA 103, 2257-2261. (Pubitemid 43271657)
77. Wada R, Akiyama Y, Hashimoto Y, Fukamachi H, Yuasa Y (2010). miR-212 is downregulated and suppresses methyl-CpG-binding protein MeCP2 in human gastric cancer. Int J Cancer 127, 1106-1114.
78. Watkins DN, Berman DM, Burkholder SG, Wang B, Beachy PA, Baylin SB (2003). Hedgehog signalling within airway epithelial progenitors and in small-cell lung cancer. Nature 422, 313-317. (Pubitemid 36378358)
79. Xie J, Aszterbaum M, Zhang X, Bonifas JM, Zachary C, Epstein E, McCormick F (2001). A role of PDGFRα in basal cell carcinoma proliferation. Proc Natl Acad Sci USA 98, 9255-9259. (Pubitemid 32743903)
80. Yanaihara N et al. (2006). Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 9, 189-198. (Pubitemid 43357945)
81. You S, Zhou J, Chen S, Zhou P, Lv J, Han X, Sun Y (2010). PTCH1, a receptor of Hedgehog signaling pathway, is correlated with metastatic potential of colorectal cancer. Ups J Med Sci 115, 169-175.
82. Yustein AS, Harper JC, Petroni GR, Cummings OW, Moskaluk CA, Powell SM (1999). Allelotype of gastric adenocarcinoma. Cancer Res 59, 1437-1441. (Pubitemid 29160106)
83. Zanca C, Cozzolino F, Quintavalle C, Di Costanzo S, Ricci-Vitiani L, Santoriello M, Monti M, Pucci P, Condorelli G (2010). PED interacts with Rac1 and regulates cell migration/invasion processes in human non-small cell lung cancer cells. J Cell Physiol 225, 63-72.
84. Zhang L et al. (2006). microRNAs exhibit high frequency genomic alterations in human cancer. Proc Natl Acad Sci USA 103, 9136-9141. (Pubitemid 43902545)